Granules India Limited (GIL) announced that it has submitted a Paragraph IV certification in connection with its ANDA for ...
Eris Lifesciences has announced the appointment of Chirag Mehta as Executive Director. He will be based at the company’s ...
According to a Tracxn report, funding in the HealthTech, Life Sciences and Healthcare sectors in India stood at $256.7M ...
Aragen OneHP provides development and cGMP manufacturing capabilities for highly potent molecules, including cytotoxic ...
Industry forum brings experts together to discuss product development, quality, regulatory compliance and manufacturing ...
Zydus Lifesciences (Zydus), in partnership with MSN Laboratories (MSN), has announced the launch of Riociguat Tablets, 0.5 mg ...
Aesthetic treatments were generally used for correction purposes until recently. The usual practice was to smooth out ...
Fixderma has grown from its 2010 launch into a company exporting to over 35 countries with a 130-plus product portfolio.
India’s CRDMO sector is gaining importance as global pharma seeks resilient, cost-efficient supply chains. Akhil Ravi, CEO, ...
The open letter from nine EU pharma leaders and China’s new five year pharma plan are the latest and clearest signals that ...
Formoflo-G MDI combines Glycopyrronium Bromide, Formoterol Fumarate and Fluticasone Propionate for the management and treatment of moderate to severe COPD ...
Glenmark Therapeutics Inc., USA (Glenmark) has announced the launch of Adapalene Gel USP, 0.1 per cent (OTC) in new pump packs in the US. Glenmark’s Adapalene Gel USP, 0.1 per cent can be compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results